Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Nizaracianine Triflutate for visualizing the ureters during abdominopelvic surgery; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nizaracianine Triflutate

Snippet

Sponsor: Curadel Surgical Innovations, Inc. | Conditions: Injury of Ureter During Surgery (Disorder) | Phase 2, Phase 3 | Status: RECRUITING